Cited by 154Preterm Birth and ChorioamnionitisNeonatal Respiratory Health ResearchNeonatal and Maternal Infections

Maternal Serum Interleukin-6, C-Reactive Protein, and Matrix Metalloproteinase-9 Concentrations as Risk Factors for Preterm Birth <32 Weeks and Adverse Neonatal Outcomes

Open access
Sorokin, Yoram, Romero, Roberto, Mele, Lisa, Wapner, Ronald, Iams, Jay, Dudley, Donald, Spong, Catherine, Peaceman, Alan +11 more·2010·American Journal of Perinatology

Abstract

Elevated concentrations of interleukin-6 (IL-6), C-reactive protein (CRP), and matrix metalloproteinase-9 (MMP-9) in fetal and neonatal compartments have been associated with an increased risk for preterm birth (PTB) and/or neonatal morbidity. The purpose of this study was to determine if the maternal serum concentration of IL-6, CRP, and MMP-9 in women at risk for PTB, who are not in labor and have intact membranes, are associated with an increased risk for PTB <32 weeks and/or neonatal morbidity. Maternal serum samples collected from 475 patients enrolled in a multicenter randomized controlled trial of single versus weekly corticosteroids for women at increased risk for preterm delivery were assayed. Serum was collected at randomization (24 to 32 weeks' gestation). Maternal serum concentrations of IL-6, CRP, and MMP-9 were subsequently determined using enzyme-linked immunoassays. Multivariate logistic regression analysis was performed to explore the relationship between maternal serum concentrations of IL-6, CRP, and MMP-9 and PTB <32 weeks, respiratory distress syndrome (RDS), chronic lung disease (CLD), intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), and any sepsis. Maternal serum concentrations of IL-6 and CRP, but not MMP-9, above the 90th percentile at the time of randomization were associated with PTB <32 weeks. In contrast, there was no significant relationship between RDS and NEC and the maternal serum concentration of IL-6, CRP, or MMP-9 (univariate analysis). The development of CLD was associated with a high (above 90th percentile) IL-6 and CRP in maternal serum, even after adjustment for gestational age (GA) at randomization and treatment group. However, when GA at delivery was added to the model, this finding was nonsignificant. Neonatal sepsis was more frequent in neonates born to mothers with a high maternal serum concentration of CRP (>90th percentile). However, there was no significant association after adjustment for GA at randomization and treatment group. Logistic regression analysis for each analyte indicated that high maternal serum concentrations of IL-6 and CRP, but not MMP-9, were associated with an increased risk of IVH (odds ratio [OR] 4.60, 95% confidence interval [CI] 1.86 to 10.68; OR 4.07, 95% CI 1.63 to 9.50) after adjusting for GA at randomization and treatment group. Most babies (25/30) had grade I IVH. When GA at delivery was included, elevated IL-6 remained significantly associated with IVH (OR 2.77, 95% CI 1.02 to 7.09). An elevated maternal serum concentration of IL-6 and CRP are risk factors for PTB <32 weeks and subsequent development of neonatal IVH. An elevated maternal serum IL-6 appears to confer additional risk for IVH even after adjusting for GA at delivery.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0030-1249366

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated gestational CRP levels are associated with adverse infant and child brain developmental outcomes.

    “Additionally, C-reactive protein (CRP), an inflammatory marker, is elevated as prenatal maternal mental distress increases [142, 143], and elevated gestational CRP levels have been associated with increased risk of preterm birth [144], adverse infant and child brain developmental outcomes [144, 145], as well as autism and schizophrenia in the offspring [146, 147].”

    From Brain structural and functional outcomes in the offspring of women experiencing psychological distress during pregnancy (2024) · cites this paper as [144]

    The Results (page not provided) associate high maternal CRP with neonatal intraventricular hemorrhage, a brain injury. The Neonatal data and outcomes section says infants were followed only until discharge or 120 days; the paper does not report child brain-development outcomes. The Results also indicate that CRP’s association with hemorrhage did not remain significant after adjustment for gestational age at delivery. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Elevated gestational CRP levels are associated with increased risk of preterm birth.

    “Additionally, C-reactive protein (CRP), an inflammatory marker, is elevated as prenatal maternal mental distress increases [142, 143], and elevated gestational CRP levels have been associated with increased risk of preterm birth [144], adverse infant and child brain developmental outcomes [144, 145], as well as autism and schizophrenia in the offspring [146, 147].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sorokin, Y., Romero, R., Mele, L., Wapner, R., Iams, J., Dudley, D., Spong, C., Peaceman, A., Leveno, K., Harper, M., Caritis, S., Miodovnik, M., Mercer, B., Thorp, J., O'Sullivan, M., Ramin, S., Carpenter, M., Rouse, D., & Sibai, B.
Affiliations
  • Wayne State University (US)
  • National Institutes of Health (US)
  • George Washington University (US)
  • Northwestern University (US)
  • The University of Texas at Dallas (US)
  • University of Pittsburgh (US)
  • University of North Carolina at Chapel Hill (US)
  • University of Tennessee Health Science Center (US)
Venue
American Journal of Perinatology
Published
2010-03-01
Volume
27
Issue
08
Pages
631-640
ISSN
  • 0735-1631 (ISSN-L)
  • 1098-8785
OpenAlex
W1999422044
Cited by
154
References
40
Citations by year
2026: 5 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 12 · 2020: 10 · 2019: 11 · 2018: 11 · 2017: 8 · 2016: 17 · 2015: 9 · 2014: 13 · 2013: 11 · 2012: 14
FWCI
8.38
Type
journal article
Language
en
Open access
Locations
  • American Journal of Perinatology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (2r24hd050924-06, UL1TR000005)
  • National Center for Research Resources (M01RR000080)
  • National Center for Advancing Translational Sciences
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD40512, U01HD036801, R24 HD-050924, HD27917, U10HD040544, U10HD034208, U10HD027861, HD-27915, U10HD040512, HD34116, UG1HD034116, HD40545, HD34136, (HD40500, U10HD027915, HD-21414, U10HD040545, U10HD040560, HD 40544, HD-27860, HD40560, HD27861, U10HD027917, U10HD036801, U10HD027905, U10HD027860, U10HD021410, HD 34208, HD 36801, U10HD034116, HD27869, [HD21410, U10HD040500, U10HD034122, U10HD040485, U10HD027869, U10HD034136, UG1HD034208, U24HD036801, UG1HD040500, UG1HD040512, UG1HD027869, UG1HD040544, UG1HD040485, UG1HD027915, UG1HD040560, UG1HD040545, HD 40485)
Topics
  • Health Sciences › Medicine › Epidemiology › Preterm Birth and Chorioamnionitis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Neonatal and Maternal Infections
Keywords
preterm birth, interleukin-6, C-reactive protein, MMP-9, maternal serum biomarkers, preterm birth risk factors, neonatal morbidity, intraventricular hemorrhage, chronic lung disease of prematurity, neonatal sepsis, necrotizing enterocolitis, respiratory distress syndrome, corticosteroid therapy, gestational age
MeSH terms
C-Reactive Protein, Female, Humans, Infant, Newborn, Infant, Newborn, Diseases, Lung Diseases, Maternal-Fetal Exchange, Pregnancy, Pregnancy Outcome, Pregnancy Trimester, Second, Pregnancy Trimester, Third, Respiratory Distress Syndrome, Newborn, Risk Factors, Biomarkers, Interleukin-6, Sepsis, Intracranial Hemorrhages, Enterocolitis, Necrotizing, Matrix Metalloproteinase 9, Premature Birth

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review